Your browser doesn't support javascript.
loading
Anti-Tumor Necrosis Factor Treatment Does Not Decrease the Risk of Type 2 Diabetes in Patients With Inflammatory Bowel Disease.
Villumsen, Marie; Poulsen, Gry; Andersen, Nynne Nyboe; Andersson, Mikael; Jess, Tine; Allin, Kristine Højgaard.
Afiliação
  • Villumsen M; Center for Clinical Research and Prevention, Copenhagen University Hospital Bispebjerg and Frederiksberg, Copenhagen, Denmark. Electronic address: marie.villumsen@regionh.dk.
  • Poulsen G; Center for Molecular Prediction of Inflammatory Bowel Disease, Department of Clinical Medicine, Aalborg University, Copenhagen, Denmark.
  • Andersen NN; Department of Gastroenterology, Køge University Hospital, Køge, Denmark.
  • Andersson M; Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
  • Jess T; Center for Molecular Prediction of Inflammatory Bowel Disease, Department of Clinical Medicine, Aalborg University, Copenhagen, Denmark; Department of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark.
  • Allin KH; Center for Molecular Prediction of Inflammatory Bowel Disease, Department of Clinical Medicine, Aalborg University, Copenhagen, Denmark; Department of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark.
Clin Gastroenterol Hepatol ; 21(12): 3182-3184.e3, 2023 11.
Article em En | MEDLINE | ID: mdl-36566818

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Diabetes Mellitus Tipo 2 Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Diabetes Mellitus Tipo 2 Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article